HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 133 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $909,000 | +154.6% | 70,942 | +157.6% | 0.02% | +150.0% |
| Q1 2017 | $357,000 | -42.8% | 27,542 | -56.4% | 0.01% | -33.3% |
| Q4 2016 | $624,000 | +77.8% | 63,184 | +117.7% | 0.02% | +87.5% |
| Q3 2016 | $351,000 | +135.6% | 29,020 | +84.9% | 0.01% | +100.0% |
| Q1 2016 | $149,000 | -18.6% | 15,695 | +48.9% | 0.00% | +33.3% |
| Q4 2015 | $183,000 | -60.7% | 10,539 | -69.6% | 0.00% | -62.5% |
| Q3 2015 | $466,000 | +87.1% | 34,663 | +213.8% | 0.01% | +100.0% |
| Q2 2015 | $249,000 | +4.2% | 11,047 | -58.0% | 0.00% | -20.0% |
| Q3 2014 | $239,000 | -33.1% | 26,282 | -27.3% | 0.01% | -16.7% |
| Q2 2014 | $357,000 | -15.0% | 36,176 | +29.1% | 0.01% | +20.0% |
| Q4 2013 | $420,000 | +63.4% | 28,015 | +20.1% | 0.01% | +66.7% |
| Q3 2013 | $257,000 | – | 23,326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |